Total Payments
$5,078
2024 Payments
$93.85
Companies
38
Transactions
231
Medicare Patients
564
Medicare Billing
$59,766
Payment Breakdown by Category
Food & Beverage$5,072 (99.9%)
Education$6.02 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,072 | 230 | 99.9% |
| Education | $6.02 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $805.10 | 40 | $0 (2019) |
| PFIZER INC. | $679.56 | 23 | $0 (2019) |
| Lilly USA, LLC | $490.66 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $426.58 | 13 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $349.02 | 16 | $0 (2020) |
| Novo Nordisk Inc | $332.48 | 25 | $0 (2021) |
| ABBVIE INC. | $301.00 | 16 | $0 (2022) |
| Astellas Pharma US Inc | $245.41 | 13 | $0 (2019) |
| Allergan Inc. | $221.49 | 19 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $140.83 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $93.85 | 1 | Lilly USA, LLC ($93.85) |
| 2022 | $32.93 | 2 | ABBVIE INC. ($32.93) |
| 2021 | $57.16 | 3 | AbbVie Inc. ($22.23) |
| 2020 | $154.25 | 5 | Optinose US, Inc. ($87.64) |
| 2019 | $1,605 | 83 | PFIZER INC. ($301.89) |
| 2018 | $1,344 | 60 | Merck Sharp & Dohme Corporation ($218.02) |
| 2017 | $1,791 | 77 | Merck Sharp & Dohme Corporation ($343.54) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $93.85 | General |
| Category: Diabetes | ||||||
| 03/15/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Obesity | ||||||
| 01/28/2020 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $87.64 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 01/27/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Diabetes | ||||||
| 01/22/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
| 01/22/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/17/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/17/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: VACCINES | ||||||
| 12/13/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/09/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Diabetes | ||||||
| 12/06/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Diabetes | ||||||
| 11/19/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $121.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Obesity | ||||||
| 11/09/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Obesity | ||||||
| 11/06/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 63 | 80 | $22,374 | $6,530 |
| 2021 | 6 | 239 | 308 | $75,717 | $31,132 |
| 2020 | 5 | 262 | 282 | $53,043 | $22,104 |
Total Patients
564
Total Services
670
Medicare Billing
$59,766
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 63 | $17,325 | $3,904 | 22.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 17 | 17 | $5,049 | $2,626 | 52.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 146 | $39,100 | $13,756 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 82 | 82 | $24,354 | $12,696 | 52.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 34 | $6,250 | $1,874 | 30.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 12 | $3,718 | $1,355 | 36.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 17 | 17 | $1,224 | $1,109 | 90.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 17 | $1,071 | $341.19 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 92 | 92 | $27,324 | $12,522 | 45.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 47 | $10,575 | $3,713 | 35.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 57 | 67 | $10,050 | $2,986 | 29.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 33 | 34 | $2,448 | $2,067 | 84.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 40 | 42 | $2,646 | $814.95 | 30.8% |
About Dr. Daniel Snow, MD
Dr. Daniel Snow, MD is a Family Medicine healthcare provider based in North Potomac, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609876481.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Snow, MD has received a total of $5,078 in payments from pharmaceutical and medical device companies, with $93.85 received in 2024. These payments were reported across 231 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,072).
As a Medicare-enrolled provider, Snow has provided services to 564 Medicare beneficiaries, totaling 670 services with total Medicare billing of $59,766. Data is available for 3 years (2020–2022), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location North Potomac, MD
- Active Since 07/22/2005
- Last Updated 09/28/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1609876481
Products in Payments
- XARELTO (Drug) $420.56
- JANUVIA (Drug) $361.52
- TRULICITY (Drug) $324.55
- ELIQUIS (Drug) $220.57
- BELSOMRA (Drug) $205.43
- STEGLATRO (Drug) $183.46
- BEVESPI AEROSPHERE (Drug) $180.56
- LYRICA (Drug) $163.35
- JARDIANCE (Drug) $163.33
- MYRBETRIQ (Drug) $158.48
- Ozempic (Drug) $125.76
- VRAYLAR (Drug) $125.10
- ENTRESTO (Drug) $123.90
- TRUMENBA (Biological) $121.36
- Veltassa (Drug) $111.31
- VERTEX (Device) $100.90
- PREVNAR - 13 (Biological) $100.56
- MOUNJARO (Drug) $93.85
- Xhance (Drug) $87.64
- Myrbetriq (Drug) $86.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.